Risk factors of early proximal gastric carcinoma in Chinese diagnosed using <scp>WHO</scp> criteria

Fang Cheng(Nanjing Drum Tower Hospital), Xiao Ping Zou(Nanjing Drum Tower Hospital), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Jason S. Gold(Memorial Sloan Kettering Cancer Center), Hiroshi Mashimo(VA Boston Healthcare System), Qi Sun(Fudan University), Jiong Shi(Nanjing Drum Tower Hospital), Gui Fang Xu(Nanjing Drum Tower Hospital), Lu Lin(Sun Yat-sen University)
Journal of Digestive Diseases
March 6, 2015
10.1111/1751-2980.12240
Cited by 23

Related Papers

Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
|Gastroenterology|2011|455
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396